seed
Stage
1
Investors
About
GENEPRED provides Melapred Access, a clinico-genetic test that calculates an individual melanoma risk score by integrating genetic markers and clinical factors to enable personalized melanoma prevention and monitoring.
Explore GENEPRED's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.